NDC product
TABLET · F. Hoffmann-La Roche Ltd
NDC 12806-8600 · F. Hoffmann-La Roche Ltd
Key facts
| Product NDC | 12806-8600 |
|---|---|
| Nonproprietary name | BALOXAVIR MARBOXIL |
| Substances | BALOXAVIR MARBOXIL |
| Dosage form | TABLET |
| Labeler | F. Hoffmann-La Roche Ltd |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Mar 26, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: